Las Vegas, NV -- (SBWIRE) -- 12/11/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: PBF Energy Inc (NYSE:PBF), Enanta Pharmaceuticals Inc (NASDAQ:ENTA), Array Bophirima Inc (NASDAQ:ARRY), XOMA Corp (NASDAQ:XOMA)
PBF Energy Inc (NYSE:PBF) managed to keep its gain at 1.20% on above-normal volume of 1.37M shares. The stock settled at $29.50 after floating in a range of $28.90 to $29.53. Its latest price has reached market capitalization of $1.17 billion. Its 52-week range has been $20.15 to $42.50. PBF Energy Inc. (PBF Energy) is an independent petroleum refiners and suppliers of unbranded transportation fuels, heating oils, petrochemical feedstocks, lubricants and other petroleum products in the United States. The Company produces a range of products at each of its refineries, including gasoline, ultra-low-sulfur diesel (ULSD), heating oil, jet fuel, lubricants, petrochemicals and asphalt.
For How Long PBF will fight for Profitability? Read This Trend Analysis report
Enanta Pharmaceuticals Inc (NASDAQ:ENTA) traded up on a volume of 1.35 million, higher than its standard daily volume. Shares have gained 28.59% to $38.14. Over the last twelve months, the stock has gained 91.37% and faced a worst price of $14.31. Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company. The Company uses its chemistry-driven approach and drug discovery capabilities to create small molecule drugs in the infectious disease field. The Company is discovering and developing novel inhibitors designed for use against the hepatitis C virus (HCV).
For How Long ENTA’s Gloss will Attract Investors? Find out via this report
Array Bophirima Inc (NASDAQ:ARRY) settled -2.68% lower at $5.09 on below -normal volume of 1.33M shares during the last trading day. The stock has its 12-month high at $7.10 and 52-week low price was $3.41. It traded in a range of $5 to $5.29 during the last trading day. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company’s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.
Will ARRY Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, XOMA Corp (NASDAQ:XOMA) was up on low volume, trading at a volume of 1.32M shares versus its average daily volume of 1.97 million shares. At $6.01, the stock has attained market capitalization of $559.40 million. XOMA Corporation (XOMA) is engaged in the discovery and development of antibody-based therapeutics. The Company’s lead drug candidate is gevokizumab (formerly XOMA 052), a humanized monoclonal allosteric modulating antibody designed to inhibit the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta).
Will XOMA Continue To Move Higher? Find Out Here
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)